258 related articles for article (PubMed ID: 28986190)
1. Incidence and Risk Factors for Nontuberculous Mycobacterial Infection after Allogeneic Hematopoietic Cell Transplantation.
Beswick J; Shin E; Michelis FV; Thyagu S; Viswabandya A; Lipton JH; Messner H; Marras TK; Kim DDH
Biol Blood Marrow Transplant; 2018 Feb; 24(2):366-372. PubMed ID: 28986190
[TBL] [Abstract][Full Text] [Related]
2. A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients.
Unal E; Yen C; Saiman L; George D; Della-Latta P; van de Ven C; Morris E; Bradley MB; Del Toro G; Garvin J; Bhatia M; Schwartz J; Satwani P; Roman E; Cooney E; Wolownik K; Hawks R; Foley S; Cairo MS
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1188-97. PubMed ID: 17085312
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterial infections in adult recipients of allogeneic hematopoietic stem cell transplantation: A cohort study in a high endemic area.
Liu YC; Wu CJ; Ko PS; Chien SH; Fan NW; Wang HY; Gau JP; Liu CJ; Hsiao LT; Chiou TJ; Liu CY; Liu JH
J Microbiol Immunol Infect; 2020 Apr; 53(2):274-282. PubMed ID: 30082145
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
5. Nontuberculous mycobacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation.
Nagata A; Sekiya N; Najima Y; Horiuchi M; Fukushima K; Toya T; Igarashi A; Kobayashi T; Kakihana K; Ohashi K; Doki N
Int J Infect Dis; 2020 Aug; 97():131-134. PubMed ID: 32474198
[TBL] [Abstract][Full Text] [Related]
6. Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
Nakamae H; Kirby KA; Sandmaier BM; Norasetthada L; Maloney DG; Maris MB; Davis C; Corey L; Storb R; Boeckh M
Biol Blood Marrow Transplant; 2009 Jun; 15(6):694-703. PubMed ID: 19450754
[TBL] [Abstract][Full Text] [Related]
7. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
[TBL] [Abstract][Full Text] [Related]
8. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections.
Gaviria JM; Garcia PJ; Garrido SM; Corey L; Boeckh M
Biol Blood Marrow Transplant; 2000; 6(4):361-9. PubMed ID: 10917571
[TBL] [Abstract][Full Text] [Related]
9. Low CD4 count may be a risk factor for non-tuberculous mycobacteria infection in pediatric hematopoietic cell transplant recipients.
Wobma H; Chang AK; Jin Z; Baker C; Garvin J; George D; Satwani P; Foca M; Bhatia M
Pediatr Transplant; 2021 Jun; 25(4):e13994. PubMed ID: 33704868
[TBL] [Abstract][Full Text] [Related]
10. High rates of infection and colonization by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation.
Weinstock DM; Feinstein MB; Sepkowitz KA; Jakubowski A
Bone Marrow Transplant; 2003 Jun; 31(11):1015-21. PubMed ID: 12774053
[TBL] [Abstract][Full Text] [Related]
11. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.
Knoll BM; Kappagoda S; Gill RR; Goldberg HJ; Boyle K; Baden LR; Fuhlbrigge AL; Marty FM
Transpl Infect Dis; 2012 Oct; 14(5):452-60. PubMed ID: 22676720
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus Infection in Allogeneic Hematopoietic Cell Transplantation Managed by the Preemptive Approach: Estimating the Impact on Healthcare Resource Utilization and Outcomes.
Huang YT; Su Y; Kim SJ; Nichols P; Burack D; Maloy M; Giralt S; Perales MA; Jakubowski AA; Papanicolaou GA
Biol Blood Marrow Transplant; 2019 Apr; 25(4):791-799. PubMed ID: 30476551
[TBL] [Abstract][Full Text] [Related]
13. Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.
Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Auletta JJ; Badawy SM; Bhatt N; Bhatt VR; Cahn JY; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Gale RP; Hashem H; Hashmi S; Hematti P; Hong S; Hossain NM; Inamoto Y; Lekakis LJ; Modi D; Patel S; Sharma A; Solomon S; Couriel DR
Transplant Cell Ther; 2022 Oct; 28(10):712.e1-712.e8. PubMed ID: 35863740
[TBL] [Abstract][Full Text] [Related]
14. Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant.
Taimur S; Askar M; Sobecks R; Rybicki L; Warshawsky I; Mossad S
Transpl Infect Dis; 2014 Feb; 16(1):61-6. PubMed ID: 24251680
[TBL] [Abstract][Full Text] [Related]
15. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
16. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.
Liu J; Kong J; Chang YJ; Chen H; Chen YH; Han W; Wang Y; Yan CH; Wang JZ; Wang FR; Chen Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Clin Microbiol Infect; 2015 Dec; 21(12):1121.e9-15. PubMed ID: 26093077
[TBL] [Abstract][Full Text] [Related]
17. Nontuberculous mycobacterial and Aspergillus infections among cadaveric lung transplant recipients in Japan.
Tachibana K; Okada Y; Matsuda Y; Miyoshi K; Oto T; Chen-Yoshikawa TF; Date H; Minami M; Okumura M; Iwasaki A; Shiraishi T; Maeda S; Matsumura Y; Nakajima T; Yoshino I; Hayashi S
Respir Investig; 2018 May; 56(3):243-248. PubMed ID: 29773296
[TBL] [Abstract][Full Text] [Related]
18. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
19. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation.
Huang YT; Neofytos D; Foldi J; Kim SJ; Maloy M; Chung D; Castro-Malaspina H; Giralt SA; Papadopoulos E; Perales MA; Jakubowski AA; Papanicolaou GA
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1480-1486. PubMed ID: 27178374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
